Semler Scientific, Inc. Announces Purchase of Additional Bitcoins for $17 Million
Semler Scientific, Inc. Makes Major Investment in Bitcoin, Purchasing Additional 247 Bitcoins
SANTA CLARA, Calif., June 6, 2024 /PRNewswire/ — Semler Scientific, Inc. (Nasdaq: SMLR), a leading developer of technology products and services for healthcare providers, has announced a significant investment in Bitcoin. The company has purchased an additional 247 bitcoins for a total of $17 million in cash, including fees and expenses.
With this latest purchase, Semler now holds a total of 828 bitcoins, acquired for a total of $57 million, inclusive of fees and expenses. This move highlights the company’s commitment to expanding its healthcare business while also recognizing the value of Bitcoin as an investment and store of value.
Semler Scientific’s CEO, Doug Murphy-Chutorian, MD, stated, “Semler remains focused on our two strategies of expanding our healthcare business and acquiring and holding Bitcoin. The company now holds 828 bitcoins, underscoring our view that Bitcoin is a compelling investment and can serve as a reliable store of value. We will continue to pursue our strategy of purchasing bitcoins with cash.”
Semler Scientific, Inc. is known for developing innovative products and services to combat chronic diseases. Its flagship product, QuantaFlo®, is a rapid point-of-care test that measures arterial blood flow in the extremities and aids in the diagnosis of cardiovascular diseases such as peripheral arterial disease (PAD). The company is also seeking a new 510(k) clearance for expanded indications for QuantaFlo.
In addition to its healthcare business, Semler Scientific has adopted Bitcoin as its primary treasury reserve asset. The company’s forward-looking statements emphasize its new Bitcoin strategy, the purchase of additional Bitcoin with cash, and the expansion of its healthcare business.
Investing in Bitcoin comes with inherent risks, including volatility and the need for a solid treasury strategy. Semler Scientific acknowledges these risks and is committed to managing them effectively.
For more information about Semler Scientific, visit www.semlerscientific.com.
Contact:
Renae Cormier
Chief Financial Officer
[email protected]
SOURCE Semler Scientific, Inc.